Evidence map›Paper›PMID 18448479›Full record

ReviewSchizophrenia bulletin2008

Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.

S Kristian Hill, Margret S H Harris, Ellen S Herbener, Mani Pavuluri, John A Sweeney

Open access · bronzeAbstract readComparative StudyReview
In one paragraph

Review in Schizophrenia bulletin, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

S Kristian HillCenter for Cognitive Medicine, Department of Psychiatry (M/C 913), University of Illinois at Chicago, 912 South Wood Street, Suite 235, Chicago, IL 60612, USA. shill@psych.uic.edu
Margret S H Harris
Ellen S Herbener
Mani Pavuluri
John A Sweeney
University of Illinois Chicago · US

Funding

Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077862 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI SWEENEY, JOHN A · 2007 to 2010
$3.1M
OCULOMOTOR &SPATIAL COGNITION DEFICITS IN SCHIZOPHRENIAR01MH062134 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWEENEY, JOHN A · 2000 to 2004
$1.8M
NIMH NIH HHS MH062134NIMH NIH HHS MH077862NIMH NIH HHS R01 MH062134NIMH NIH HHS R01 MH077862
6 · The paper itself

Abstract

Psychiatric disorders are genetically complex and represent the end product of multiple biological and social factors. Links between genes and disorder-related abnormalities can be effectively captured via assessment of phenotypes that are both associated with genetic effects and potentially contributory to behavioral abnormalities. Identifying intermediate or allied phenotypes as a strategy for clarifying genetic contributions to disorders has been successful in other areas of medicine and is a promising strategy for identifying susceptibility genes in complex psychiatric disorders. There is growing evidence that schizophrenia and bipolar disorder, rather than being wholly distinct disorders, share genetic risk at several loci. Further, there is growing evidence of similarity in the pattern of cognitive and neurobiological deficits in these groups, which may be the result of the effects of these common genetic factors. This review was undertaken to identify patterns of performance on neurocognitive and affective tasks across probands with schizophrenia and bipolar disorder as well as unaffected family members, which warrant further investigation as potential intermediate trait markers. Available evidence indicates that measures of attention regulation, working memory, episodic memory, and emotion processing offer potential for identifying shared and illness-specific allied neurocognitive phenotypes for schizophrenia and bipolar disorder. However, very few studies have evaluated neurocognitive dimensions in bipolar probands or their unaffected relatives, and much work in this area is needed.

Indexed as

AdolescentAdultAge of OnsetBipolar DisorderChildCognition DisordersDelusionsFamilyGenetic Predisposition to DiseaseHallucinationsHumansMolecular BiologyNeuropsychological TestsPhenotypeResearch DesignSchizophrenia

Identifiers

PMID18448479
PMCPMC2632447
OpenAlexW2115117896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.